In the ALI murine model, we demonstrated that SCIMPN could increase the survival rate, accelerate CD11b+Ly6G+ neutrophils infiltration, and help with bacterial clearance, but they did not influence the percentage of CD11b+CD11c+F4/80+ AM cells in the lung. This evidence concerns the gene ITGAX and acute respiratory distress syndrome.